Palantir Technologies (NASDAQ:PLTR) has handed retirement investors a wild ride in 2026. Shares of Palantir closed Friday at $112.93, down 12.1% over the past weekPalantir Technologies (NASDAQ:PLTR) has handed retirement investors a wild ride in 2026. Shares of Palantir closed Friday at $112.93, down 12.1% over the past week

Palantir Price Prediction: The Stock Will Hit $150 on This Date

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The post Palantir Price Prediction: The Stock Will Hit $150 on This Date appeared first on 24/7 Wall St..

Palantir Technologies (NASDAQ:PLTR) has handed retirement investors a wild ride in 2026. Shares of Palantir closed Friday at $112.93, down 12.1% over the past week, 14.78% over the past month, and 36.47% year to date from a starting price of $177.75. The one year change sits at negative 21.71%, and the stock is roughly 46% below its 52 week high of $207.52.

Despite the pullback, most of the Street still holds moderate forecasts. The consensus 12 month analyst target sits at $182.75, with 18 Buy ratings, 10 Holds, and a couple of bears.

But veteran Rosenblatt Securities analyst John McPeake made waves earlier this year when he initiated coverage on February 27, 2026 with a Buy rating and a $150 price target, calling Palantir a market disrupting AI infrastructure play. From today’s price, that target implies meaningful upside by year end 2026.

That is well above the Polymarket crowd, which currently assigns just a 7% probability to PLTR hitting $150 in July, and below the broader sell side consensus. But can PLTR realistically reach $150 by the end of 2026?

An infographic titled 'Palantir: The Path to $150 - 2026 Outlook & Key Growth Drivers - As of June 28, 2026'. It is divided into several sections. The 'Current Snapshot' shows a current price of $112.93, YTD Change of -36.47%, 1-Week Change of -12.1%, 1-Month Change of -14.78%, and a 52-Week Range from $106.37 to $207.52, with a bar chart indicating the current price is roughly 46% below its 52-week high. The '$150 Target & Analyst View' section highlights a $150 price target from Rosenblatt Securities, a consensus 12-month analyst target of $182.75, and a Polymarket Probability of 7% for $150 in July 2026. The 'Key Growth Drivers & Financial Momentum' section details U.S. Commercial Revenue (Q1 2026) at $595M (+133% YoY) with a Remaining Deal Value of $4.92B, U.S. Government Revenue (Q1 2026) at $687M (+84% YoY), and Q1 Free Cash Flow of $924.6M with FY2026 Adjusted FCF Guidance of $4.2 - $4.4B. The 'What Will It Take To Reach $150?' section lists three points: deliver on FY2026 revenue guidance of $7.65 - $7.66B, maintain operating margins near ~46%, and hold a forward multiple near ~77x Forward P/E. The 'Risk & Outlook' section states the Primary Risk as 'Multiple Compression', Beta as 1.515 (High), and P/E as 127, with a summary text about the $150 target being grounded by accelerating revenue and strong backlog.24/7 Wall St.

McPeake’s thesis rests on operating leverage that is showing up in the numbers right now. Palantir’s Q1 2026 revenue grew 84.7% year over year to $1.632 billion, the highest growth rate in company history, and GAAP operating income reached $754 million at a 46% margin. CEO Alex Karp noted the “Rule of 40 score has soared to 145%”, a level matched only by NVIDIA, Micron, and SK hynix.

Key Drivers of PLTR Stock Performance

  1. AIP enterprise adoption. U.S. commercial revenue jumped 133% year over year to $595 million in Q1, with remaining deal value of $4.92 billion. For long term retirement accounts, that backlog supports years of compounding revenue over multiple quarters.
  2. Government AI spending. U.S. government revenue grew 84% year over year to $687 million. Defense and intelligence contracts are durable and renewable, the kind of recurring base retirement portfolios prize.
  3. Free cash flow generation. Q1 free cash flow hit $924.6 million, and management guides FY2026 adjusted free cash flow of $4.2 to $4.4 billion. Compounding cash flow at this scale is what funds buybacks, R&D, and the next leg of value creation.

What Will It Take for PLTR to Reach $150?

The math is clean. With 2,296,071,000 shares outstanding, $150 implies a materially larger market cap than today’s $270.7 billion. Three conditions need to hold:

  • Palantir delivers on its raised FY2026 revenue guide of $7.65 to $7.66 billion, a 71% growth rate.
  • Operating margins stay near the 46% Q1 mark, validating the Rule of 40 narrative.
  • The forward multiple holds near its current 77x, justified by triple digit U.S. commercial growth.

The primary risk is multiple compression: a high beta of 1.515 and a P/E of 127 leave little margin for any guidance miss. Even so, with revenue growth accelerating, margins expanding, and a $4.92 billion U.S. commercial backlog already in hand, McPeake’s $150 target for year end 2026 looks well grounded, and the long term compounding story remains a credible anchor for retirement portfolios.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Palantir didn’t make the cut. Grab the names FREE today.

The post Palantir Price Prediction: The Stock Will Hit $150 on This Date appeared first on 24/7 Wall St..

Market Opportunity
WilderWorld Logo
WilderWorld Price(WILD)
$0.01697
$0.01697$0.01697
+0.77%
USD
WilderWorld (WILD) Live Price Chart

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.